CME Earnings & Financial Statements
CME Group Inc.
$285.59
+$7.56(+2.72%)
76
Overall
100
Value
66
Tech
63
Quality
Market Cap
$102.69B
Volume
1.97M
52W Range
$218.31 - $329.16
Target Price
$289.29
CME earnings and financial statements: CME Group Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CME Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B |
| Cost of revenue | $907.00M | $850.30M | $828.60M | $753.10M | $837.00M |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B |
| EBITDA | $5.83B | $5.04B | $4.67B | $4.02B | $3.93B |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B |
| EPS (diluted) | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $198.42B | $137.45B | $129.71B | $174.18B | $196.78B |
| Total liabilities | $169.70B | $110.96B | $102.97B | $147.30B | $169.38B |
| Shareholders’ equity | $28.73B | $26.49B | $26.74B | $26.88B | $27.40B |
| Cash and equivalents | $4.42B | $2.89B | $2.91B | $2.72B | $2.83B |
| Long-term debt | $3.42B | $2.68B | $3.43B | $3.42B | $2.70B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $4.28B | $3.69B | $3.45B | $3.06B | $2.40B |
| Capital expenditure | -$83.50M | -$94.00M | -$76.40M | -$89.70M | -$127.20M |
| Free cash flow | $4.19B | $3.60B | $3.38B | $2.97B | $2.28B |
| Dividends paid | $3.93B | $3.58B | $3.24B | - | $2.19B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CME | $285.59 | +2.7% | 1.97M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |